vs
Side-by-side financial comparison of Bausch Health Companies Inc. (BHC) and DTE Energy (DTE). Click either name above to swap in a different company.
DTE Energy is the larger business by last-quarter revenue ($4.4B vs $2.8B, roughly 1.6× Bausch Health Companies Inc.). DTE Energy runs the higher net margin — 8.3% vs -3.7%, a 12.0% gap on every dollar of revenue. On growth, DTE Energy posted the faster year-over-year revenue change (28.9% vs 9.3%). Over the past eight quarters, DTE Energy's revenue compounded faster (16.9% CAGR vs 14.0%).
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic ph...
DTE Energy is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services in the United States and Canada. Its operating units include an electric utility serving 2.2 million customers and a natural gas utility serving 1.3 million customers in Michigan.
BHC vs DTE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $4.4B |
| Net Profit | $-103.0M | $369.0M |
| Gross Margin | — | — |
| Operating Margin | 17.0% | 15.9% |
| Net Margin | -3.7% | 8.3% |
| Revenue YoY | 9.3% | 28.9% |
| Net Profit YoY | -205.1% | 26.4% |
| EPS (diluted) | $-0.30 | $1.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8B | $4.4B | ||
| Q3 25 | $2.7B | $3.5B | ||
| Q2 25 | $2.5B | $3.4B | ||
| Q1 25 | $2.3B | $4.4B | ||
| Q4 24 | $2.6B | $3.4B | ||
| Q3 24 | $2.5B | $2.9B | ||
| Q2 24 | $2.4B | $2.9B | ||
| Q1 24 | $2.2B | $3.2B |
| Q4 25 | $-103.0M | $369.0M | ||
| Q3 25 | $179.0M | $419.0M | ||
| Q2 25 | $148.0M | $229.0M | ||
| Q1 25 | $-58.0M | $445.0M | ||
| Q4 24 | $98.0M | $292.0M | ||
| Q3 24 | $-85.0M | $477.0M | ||
| Q2 24 | $10.0M | $322.0M | ||
| Q1 24 | $-64.0M | $313.0M |
| Q4 25 | 17.0% | 15.9% | ||
| Q3 25 | 23.1% | 17.6% | ||
| Q2 25 | 17.5% | 12.5% | ||
| Q1 25 | 12.2% | 14.1% | ||
| Q4 24 | 21.8% | 16.2% | ||
| Q3 24 | 12.7% | 17.8% | ||
| Q2 24 | 16.2% | 17.5% | ||
| Q1 24 | 13.1% | 16.0% |
| Q4 25 | -3.7% | 8.3% | ||
| Q3 25 | 6.7% | 11.9% | ||
| Q2 25 | 5.8% | 6.7% | ||
| Q1 25 | -2.6% | 10.0% | ||
| Q4 24 | 3.8% | 8.5% | ||
| Q3 24 | -3.4% | 16.4% | ||
| Q2 24 | 0.4% | 11.2% | ||
| Q1 24 | -3.0% | 9.7% |
| Q4 25 | $-0.30 | $1.78 | ||
| Q3 25 | $0.48 | $2.01 | ||
| Q2 25 | $0.40 | $1.10 | ||
| Q1 25 | $-0.16 | $2.14 | ||
| Q4 24 | $0.24 | $1.41 | ||
| Q3 24 | $-0.23 | $2.30 | ||
| Q2 24 | $0.03 | $1.55 | ||
| Q1 24 | $-0.17 | $1.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $208.0M |
| Total DebtLower is stronger | $20.8B | $23.8B |
| Stockholders' EquityBook value | $-554.0M | $12.3B |
| Total Assets | $26.4B | $54.1B |
| Debt / EquityLower = less leverage | — | 1.93× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $208.0M | ||
| Q3 25 | $1.3B | $34.0M | ||
| Q2 25 | $1.7B | $32.0M | ||
| Q1 25 | $1.1B | $33.0M | ||
| Q4 24 | $1.2B | $24.0M | ||
| Q3 24 | $719.0M | $969.0M | ||
| Q2 24 | $595.0M | $20.0M | ||
| Q1 24 | $733.0M | $292.0M |
| Q4 25 | $20.8B | $23.8B | ||
| Q3 25 | $21.0B | $24.5B | ||
| Q2 25 | $21.7B | $22.9B | ||
| Q1 25 | $21.5B | $21.8B | ||
| Q4 24 | $21.6B | $20.7B | ||
| Q3 24 | $21.5B | $20.5B | ||
| Q2 24 | $21.7B | $19.3B | ||
| Q1 24 | $22.1B | $19.2B |
| Q4 25 | $-554.0M | $12.3B | ||
| Q3 25 | $-565.0M | $12.2B | ||
| Q2 25 | $-764.0M | $11.7B | ||
| Q1 25 | $-1.2B | $11.9B | ||
| Q4 24 | $-1.3B | $11.7B | ||
| Q3 24 | $-1.2B | $11.6B | ||
| Q2 24 | $-1.2B | $11.1B | ||
| Q1 24 | $-1.1B | $11.2B |
| Q4 25 | $26.4B | $54.1B | ||
| Q3 25 | $26.8B | $52.0B | ||
| Q2 25 | $27.3B | $50.2B | ||
| Q1 25 | $26.4B | $49.6B | ||
| Q4 24 | $26.5B | $48.8B | ||
| Q3 24 | $26.5B | $49.8B | ||
| Q2 24 | $26.5B | $47.8B | ||
| Q1 24 | $26.9B | $45.9B |
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 1.96× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.77× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $495.0M | $1.0B |
| Free Cash FlowOCF − Capex | $403.0M | — |
| FCF MarginFCF / Revenue | 14.4% | — |
| Capex IntensityCapex / Revenue | 3.3% | — |
| Cash ConversionOCF / Net Profit | — | 2.84× |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $495.0M | $1.0B | ||
| Q3 25 | $405.0M | $632.0M | ||
| Q2 25 | $289.0M | $709.0M | ||
| Q1 25 | $211.0M | $1.0B | ||
| Q4 24 | $601.0M | $1.1B | ||
| Q3 24 | $405.0M | $758.0M | ||
| Q2 24 | $380.0M | $759.0M | ||
| Q1 24 | $211.0M | $1.0B |
| Q4 25 | $403.0M | — | ||
| Q3 25 | $314.0M | — | ||
| Q2 25 | $190.0M | — | ||
| Q1 25 | $96.0M | — | ||
| Q4 24 | $495.0M | — | ||
| Q3 24 | $334.0M | — | ||
| Q2 24 | $302.0M | — | ||
| Q1 24 | $129.0M | — |
| Q4 25 | 14.4% | — | ||
| Q3 25 | 11.7% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 6.0% | — |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 3.8% | — |
| Q4 25 | — | 2.84× | ||
| Q3 25 | 2.26× | 1.51× | ||
| Q2 25 | 1.95× | 3.10× | ||
| Q1 25 | — | 2.29× | ||
| Q4 24 | 6.13× | 3.71× | ||
| Q3 24 | — | 1.59× | ||
| Q2 24 | 38.00× | 2.36× | ||
| Q1 24 | — | 3.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHC
| Bausch Lomb | $1.4B | 50% |
| Salix Segment | $693.0M | 25% |
| International Rx | $306.0M | 11% |
| Diversified Segment | $255.0M | 9% |
| Solta Medical Segment | $137.0M | 5% |
DTE
| Electric Segment | $1.8B | 40% |
| Residential | $723.0M | 16% |
| Gas Segment | $651.0M | 15% |
| Commercial | $524.0M | 12% |
| Other | $333.0M | 8% |
| DTE Vantage Segment | $176.0M | 4% |
| Industrial | $159.0M | 4% |
| End User Transportation | $69.0M | 2% |
| Intermediate Transportation | $25.0M | 1% |
